ライフサイエンスコーパス: absorptiometry

1 , and body composition via dual-energy x-ray absorptiometry.

2 dy fat (LBF) was imaged by dual-energy x-ray absorptiometry.

3 -free mass and fat mass by dual-energy X-ray absorptiometry.

4 osition was measured using dual-energy x-ray absorptiometry.

5 ine (LS), as determined by dual-energy X-ray absorptiometry.

6 age fat (TBPF) measured by dual-energy X-ray absorptiometry.

7 ty that is not provided by dual-energy x-ray absorptiometry.

8 tion was assessed by using dual-energy X-ray absorptiometry.

9 ubjects underwent standard dual-energy x-ray absorptiometry.

10 eoporosis, measured by the dual-energy X-ray absorptiometry.

11 from baseline, assessed by dual-energy x-ray absorptiometry.

12 tion was measured by using dual-energy X-ray absorptiometry.

13 bar spine and total hip by dual-energy X-ray absorptiometry.

14 ty was determined by using dual-energy x-ray absorptiometry.

15 -L4) was measured by using dual-energy X-ray absorptiometry.

16 d fat-free mass index with dual-energy X-ray absorptiometry.

17 body fat (%BF) measured by dual energy X-ray absorptiometry.

18 , and muscle mass by using dual-energy X-ray absorptiometry.

19 measurements obtained from dual-energy x-ray absorptiometry.

20 sity (BMD) was assessed by dual-energy x-ray absorptiometry.

21 and waist circumference on dual-energy x-ray absorptiometry.

22 density, was determined by dual-energy X-ray absorptiometry.

23 by a whole-body scan using dual-energy X-ray absorptiometry.

24 percentage was measured by dual-energy X-ray absorptiometry.

25 BMD were measured by using dual-energy X-ray absorptiometry.

26 l neck and/or lumbar spine) using dual x-ray absorptiometry.

27 ass (FFM) were measured by dual-energy X-ray absorptiometry.

28 BMD was measured by using dual-energy X-ray absorptiometry.

29 ng Index (HEI) values, and dual-energy X-ray absorptiometry.

30 FFM were measured by using dual-energy X-ray absorptiometry.

31 ody composition was quantified by dual x-ray absorptiometry.

32 n mass were measured using dual-energy-x-ray absorptiometry.

33 tion was measured by using dual-energy X-ray absorptiometry.

34 , and hip were measured by dual-energy X-ray absorptiometry.

35 ne BMCs were measured with dual-energy X-ray absorptiometry.

36 3 y were measured by using dual-energy X-ray absorptiometry.

37 at age 9 y with the use of dual-energy X-ray absorptiometry.

38 hip and lumbar spine using dual-energy x-ray absorptiometry.

39 ne density was measured by dual-energy x-ray absorptiometry.

40 (FFMI) were measured with dual-energy X-ray absorptiometry.

41 sured at baseline and annually by dual x-ray absorptiometry.

42 lorimetry and body composition by dual x-ray absorptiometry.

43 Fat mass was assessed with dual-energy X-ray absorptiometry.

44 MD of the lumbar spine and hip at dual x-ray absorptiometry.

45 sessed by using total-body dual-energy X-ray absorptiometry.

46 g with fatness measured by dual-energy X-ray absorptiometry.

47 y fat and fat-free mass by dual-energy X-ray absorptiometry.

48 e measured with the use of dual-energy X-ray absorptiometry.

49 ass were measured by using dual-energy X-ray absorptiometry.

50 n changes were measured by dual-energy X-ray absorptiometry.

51 d at birth with the use of dual-energy X-ray absorptiometry.

52 , typically assessed using dual-energy X-ray absorptiometry.

53 ys and body composition by dual-energy X-ray absorptiometry.

54 ent of tHcy and whole-body dual-energy X-ray absorptiometry.

55 ean mass) were measured by dual-energy X-ray absorptiometry.

56 mposition were assessed by dual-energy X-ray absorptiometry.

57 g was assessed at birth by dual-energy X-ray absorptiometry.

58 e child were assessed with dual-energy X-ray absorptiometry.

59 at 3 WHI clinics by using dual-energy X-ray absorptiometry.

60 BMD by dual-energy x-ray absorptiometry, 25-hydroxyvitamin D levels, and other la

61 , and appendicular mass by dual-energy X-ray absorptiometry; activity-related energy expenditure (ARE

62 Body composition (dual-energy X-ray absorptiometry), ad libitum energy intake (EI; buffet),

63 omposition was measured by dual-energy X-ray absorptiometry and abdominal computed tomographic scans.

64 Dual-energy X-ray absorptiometry and abdominal computed tomography were us

65 Dual-energy x-ray absorptiometry and anthropometric data were used to dete

66 s, and body composition by dual-energy X-ray absorptiometry and BP at 9 years, were analysed (n = 657

67 n and abdominal adiposity (dual energy X-ray absorptiometry and computed tomography scan, respectivel

68 were assessed by combining dual-energy X-ray absorptiometry and computed tomography scanning.

69 late to regional fat gain (dual energy X-ray absorptiometry and computed tomography) and baseline pre

70 osition (measured by using dual-energy X-ray absorptiometry and computed tomography), insulin sensiti

71 Body fat was measured with dual energy X-ray absorptiometry and computed tomography.

72 s with fat measurements by dual-energy x-ray absorptiometry and computed tomography.

73 tribution were measured by dual-energy x-ray absorptiometry and computed tomography.

74 ssed with a combination of dual-energy X-ray absorptiometry and computed tomography.

75 at the endpoint by use of dual-energy X-ray absorptiometry and computed tomography.

76 Lean mass was estimated by dual X-ray absorptiometry and examined as leg lean mass (LLM), ALM,

77 percentage fat measured by dual-energy X-ray absorptiometry and fasting serum leptin concentrations w

78 sts, and total body fat by dual-energy X-ray absorptiometry and intra-abdominal and subcutaneous abdo

79 actures have lower aBMD by dual-energy x-ray absorptiometry and lower vBMD, thinner cortices, and tra

80 asured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); cir

81 at mass, fat distribution (dual-energy X-ray absorptiometry and magnetic resonance imaging), and meta

82 ) body fat distribution by dual energy x-ray absorptiometry and magnetic resonance imaging.

83 fat ratio with the use of dual-energy X-ray absorptiometry and measured the preperitoneal abdominal

84 ity was analyzed using peripheral dual x-ray absorptiometry and micro-computed tomography.

85 llas Heart Study underwent dual energy x-ray absorptiometry and MRI assessment of fat distribution, L

86 d muscle size using dual-energy radiographic absorptiometry and muscle histology.

87 nt body fat (BF) was assessed via dual X-ray absorptiometry and PA was determined via a multi-sensor

88 as evaluated by means of dual-emission x-ray absorptiometry and skinfold thickness.

89 6% body fat, by whole-body dual-energy X-ray absorptiometry) and insulin action (glucose disposal rat

90 bed rest, lean body mass (dual-energy X-ray absorptiometry) and quadriceps cross-sectional area (CSA

91 graphy), body composition (dual-energy x-ray absorptiometry), and blood parameters.

92 n force, body composition (dual-energy X-ray absorptiometry), and muscle cross-sectional area (magnet

93 er min), body composition (dual-energy X-ray absorptiometry), and relevant hormonal/metabolic blood v

94 ment (echocardiography and dual-energy x-ray absorptiometry); and histology and molecular evaluation.

95 forearm, and whole body by dual-energy x-ray absorptiometry, and a complete oral health examination w

96 ing the 4-component model, dual-energy X-ray absorptiometry, and anthropometry in 234 healthy UK chil

97 spine, and whole-body, by dual-energy x-ray absorptiometry, and at the heel by ultrasound.

98 us-glucose-tolerance test, dual-energy X-ray absorptiometry, and computed tomography, respectively.

99 MD) were assessed by using dual-energy X-ray absorptiometry, and fasting blood was collected for the

100 position was quantified by dual-energy x-ray absorptiometry, and insulin resistance was assessed by g

101 omposition was measured by dual-energy X-ray absorptiometry, and insulin sensitivity was measured by

102 dy fat was determined with dual-energy X-ray absorptiometry, and intraabdominal adipose tissue (IAAT)

103 sonance (MR) spectroscopy, dual-energy x-ray absorptiometry, and multislice abdominal MR imaging to d

104 total fat mass index from dual-energy x-ray absorptiometry, and overweight or obesity, defined as a

105 water, body composition by dual-energy X-ray absorptiometry, and physical activity by accelerometry.

106 :gynoid fat ratio by using dual-energy X-ray absorptiometry, and preperitoneal abdominal fat by using

107 omposition with the use of dual-energy X-ray absorptiometry, and questionnaire-derived perceptions of

108 urine calcium measurement, dual-energy x-ray absorptiometry, and supplementation for vitamin D defici

109 by physical examinations, dual-energy x-ray absorptiometry, and ultrasound, respectively.

110 O2]), percent body fat via dual-energy x-ray absorptiometry, and visceral fat via magnetic resonance,

111 omposition Study underwent dual-energy X-ray absorptiometry annually from 1997 to 2003.

112 mass (FM) were assessed by dual-energy X-ray absorptiometry annually over a mean (+/-SD) of 4.9 +/- 1

113 amp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visc

114 Dual x-ray absorptiometry-assessed body composition (including lean

115 e aged 4 and 6 y were BMI, dual-energy X-ray absorptiometry-assessed fat mass, overweight, or obesity

116 nd at 4 and 6 y of age for dual-energy X-ray absorptiometry assessment of lean and fat mass.

117 In a subgroup (n = 766), dual-energy X-ray absorptiometry assessment of total abdominal fat was per

118 body composition analysis (dual-energy X-ray absorptiometry), assessment of glucocorticoid metabolism

119 k) were evaluated by using dual-energy X-ray absorptiometry at 5 and 20 wk postpartum.

120 who had been scanned with dual-energy X-ray absorptiometry at 52 wk of lactation (L52; n = 79) were

121 body composition was assessed by dual X-ray absorptiometry at age 2 weeks.

122 he offspring had undergone dual-energy x-ray absorptiometry at age 9-10 years.

123 mineral density was measured with dual x-ray absorptiometry at baseline and again an average of 4.6 y

124 MD) were assessed by using dual-energy X-ray absorptiometry at baseline and at 2 annual follow-up vis

125 100, was measured by using dual-energy X-ray absorptiometry at baseline and at 3 y.

126 was measured by total-body dual-energy x-ray absorptiometry at study baseline and at 12, 24, and 36 m

127 s measured with the use of dual-energy X-ray absorptiometry at Tanner stage 4.

128 nthropometric measures and dual-energy X-ray absorptiometry at the baseline visit.

129 Patients underwent dual x-ray absorptiometry at the hip and spine and hand radiography

130 bone area were assessed by dual-energy X-ray absorptiometry at the median age of 6 y.

131 al body bone mass by using dual-energy X-ray absorptiometry at the median age of 6.0 y.

132 (BMC) Z-scores measured by dual energy X-ray absorptiometry at the one-third distal radius, in a coho

133 mineral density (aBMD) by dual-energy x-ray absorptiometry at the spine, hip, and radius, and we mea

134 m baseline in areal BMD by dual-energy x-ray absorptiometry at the total hip through month 12 (mean o

135 on than that achieved with dual-energy x-ray absorptiometry-based BMD.

136 tion of anthropometric and dual-energy X-ray absorptiometry-based measures of adiposity with IS [QUan

137 omposition was measured by dual-energy x-ray absorptiometry biweekly, resting energy expenditure was

138 density (BMD) measured by dual-energy X-ray absorptiometry, blood samples, diet, physical activity,

139 omposition with the use of dual-energy X-ray absorptiometry, blood volume with the use of a carbon mo

140 luated in association with dual-energy x-ray absorptiometry body composition measures among 15,028 ad

141 Using yearly dual-energy x-ray absorptiometry, body composition was assessed in the Hea

142 eral content obtained from dual-energy X-ray absorptiometry, body density from underwater weighing wi

143 knesses, and waist girth), dual-energy X-ray absorptiometry, body density, bioelectrical impedance, a

144 ity (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructural proper

145 ues such as anal cytology, dual energy x-ray absorptiometry, carotid ultrasonography, echocardiograph

146 ition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, and blo

147 fat, and adipocyte size by dual-energy X-ray absorptiometry, CT scan, and adipose tissue biopsy in 26

148 Genome Project focusing on Dual-Energy X-Ray Absorptiometry data for the analysis of mouse knockout d

149 Whole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NHANES w

150 basis of NHANES 1999-2004 dual-energy X-ray absorptiometry data, provide a reference in the US adult

151 Measures of dual-energy X-ray absorptiometry-derived fat mass included the limb-to-tru

152 England aged 21-60 y with dual-energy X-ray absorptiometry-derived fat mass indexes </=11 kg/m(2) in

153 England aged 21-60 y with dual-energy X-ray absorptiometry-derived fat mass indexes of >/=13 kg/m(2)

154 ciaries with HIV underwent dual energy x-ray absorptiometry (DEXA) screening in 2001-2.

155 Dual X-ray absorptiometry (DEXA) was used to determine bone mineral

156 gnetic resonance imaging (MRI) and dual Xray absorptiometry (DEXA).

157 luated fat distribution by dual-energy X-ray absorptiometry (DEXA).

158 ce underwent live imaging (dual energy x-ray absorptiometry [DEXA] scanning, two-dimensional echocard

159 Lumbar spine dual X-ray absorptiometry does not consistently distinguish childre

160 ed the newly described method of dual photon absorptiometry (DPA) to demonstrate that osteoporotic wo

161 easures compare with FM by dual-energy X-ray absorptiometry (DXA) 2 wk postpartum.

162 measures obtained by using dual-energy X-ray absorptiometry (DXA) and anthropometric measures.

163 otal body protein by using dual-energy X-ray absorptiometry (DXA) and bioimpedance analysis (BIA).

164 adipose tissue measured by dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI

165 subsequent development of dual-energy x-ray absorptiometry (DXA) and quantitative computed tomograph

166 and bone mineral density (BMD) by Dual X-Ray Absorptiometry (DXA) and repeated after 12 weeks of regu

167 ), waist circumference and Dual-energy X-ray absorptiometry (DXA) assessed fat mass), and logistic re

168 asure with the use of only dual-energy X-ray absorptiometry (DXA) attenuation values for use in Lohma

169 ort members with age 15 yr dual-energy x-ray absorptiometry (DXA) bone outcomes (whole body, lumbar s

170 rs old in 1976 underwent a dual-energy X-ray absorptiometry (DXA) bone scan.

171 Dual energy X-ray absorptiometry (DXA) can be used to determine abdominal

172 Dual-energy x-ray absorptiometry (DXA) can provide accurate measurements o

173 etic resonance imaging and dual-energy X-ray absorptiometry (DXA) estimates of evaluated components i

174 5 (mean 8.3 years apart) and hip dual x-ray absorptiometry (DXA) had been performed (2 years after b

175 mechanical CT analysis and dual-energy x-ray absorptiometry (DXA) in 136 women (age range, 43-92 year

176 es for the clinical use of dual-energy X-ray absorptiometry (DXA) in the diagnosis and treatment of o

177 y (CT) in combination with dual-energy x-ray absorptiometry (DXA) is cost-effective as a screening to

178 e mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is the primary way to identify asym

179 7 years) using anthropometric and dual X-ray absorptiometry (DXA) measurements.

180 Recently, dual-energy X-ray absorptiometry (DXA) modeling of organ-tissue mass combi

181 e food intake measures and dual-energy X-ray absorptiometry (DXA) scan for body composition will be c

182 )R-knockout) mice was analyzed by dual x-ray absorptiometry (DXA) scanning, and the trabecular and co

183 (DLW) along with multiple dual-energy X-ray absorptiometry (DXA) scans to measure changes in body en

184 Dual-energy x-ray absorptiometry (DXA) scans were performed before startin

185 ty at week 48, assessed by dual energy x-ray absorptiometry (DXA) scans.

186 Dual-energy X-ray absorptiometry (DXA) was used for an assessment of bone

187 minal multidetector CT and dual-energy x-ray absorptiometry (DXA) within 6 months of each other betwe

188 within 2 weeks of birth by dual-energy x-ray absorptiometry (DXA), analysed in all randomly assigned

189 e mineral density (BMD) by dual-energy x-ray absorptiometry (DXA), and BMD by quantitative computed t

190 ts aged 8 to 20 years with dual-energy x-ray absorptiometry (DXA), anthropometric, demographic, and p

191 Participants had dual-energy x-ray absorptiometry (DXA), entered a clinical BMD registry, a

192 tence, and remodeling with dual energy x-ray absorptiometry (DXA), high-resolution peripheral quantit

193 sment Tool (FRAX), without dual-energy X-ray absorptiometry (DXA), in all HIV-infected men aged 40-49

194 f Pb on bone quality using dual-energy X-ray absorptiometry (DXA), micro-computed tomography, Raman s

195 y composition, measured by dual-energy x-ray absorptiometry (DXA), to increased serum alanine aminotr

196 ernate measure of obesity, dual-energy X-ray absorptiometry (DXA)-derived visceral-fat-volume measure

197 mposition were measured by dual-energy X-ray absorptiometry (DXA).

198 l BMD were determined with dual-energy x-ray absorptiometry (DXA).

199 L4) were measured by using dual-energy X-ray absorptiometry (DXA).

200 ge 20 y through the use of dual-energy X-ray absorptiometry (DXA).

201 dy composition was measured using dual x-ray absorptiometry (DXA).

202 els; (3) total body fat by dual energy x-ray absorptiometry (DXA); (4) liver and muscle insulin sensi

203 ergy stores [measured with dual-energy X-ray absorptiometry (DXA)] and energy expenditure [measured w

204 offspring fatness (BMI and dual-energy X-ray absorptiometry [DXA] determined fat mass index [FMI]) in

205 Bone densities (dual x-ray absorptiometry [DXA]) were normal, low, or osteoporotic

206 ging methods (radiography, dual-energy x-ray absorptiometry [DXA], and quantitative computed tomograp

207 alternative tests (central dual-energy x-ray absorptiometry [DXA], calcaneal quantitative ultrasonogr

208 Leg lean mass (via dual-energy X-ray absorptiometry; DXA) and strength were determined.

209 equal to 2 posttransplant dual energy X-ray absorptiometry examinations.

210 imetry), body composition (dual-energy X-ray absorptiometry), fasting appetite ratings (visual analog

211 of dynamic knee loads as well as dual x-ray absorptiometry for determination of bone mineral density

212 and bone mass measured by dual-energy X-ray absorptiometry for each study year.

213 th RA underwent total body dual-energy x-ray absorptiometry for measurement of total and regional bod

214 non-RA controls underwent dual-energy x-ray absorptiometry for measurement of total and regional bod

215 nds that clinicians obtain dual-energy x-ray absorptiometry for men who are at increased risk for ost

216 mposition data measured by dual-energy X-ray absorptiometry from NHANES.

217 e mass were measured using dual energy x-ray absorptiometry; grip strength and information on lifesty

218 meters were analyzed using dual energy x-ray absorptiometry, histomorphometry, and vertebral compress

219 Body composition (by absorptiometry), HMW adiponectin, and IGF-I were assesse

220 an (SD) whole-body BMD z score by dual x-ray absorptiometry improved by 0.25 (0.78) in the interventi

221 etal muscle mass using whole-body dual X-ray absorptiometry in 142 adult lung transplant candidates.

222 19 y was measured by using dual-energy X-ray absorptiometry in 1999-2004 as part of a health examinat

223 n g/cm(2)) was measured by dual-energy X-ray absorptiometry in 2544 men and women (mean age: 58.5 y)

224 tion was measured by using dual-energy X-ray absorptiometry in 294 adult women at risk of weight gain

225 tion was measured by using dual-energy X-ray absorptiometry in 50 female, adult patients with AN befo

226 and FM were assessed using dual-energy x-ray absorptiometry in 78 CD subjects at diagnosis, 6, 12, an

227 dy composition measured by dual-energy X-ray absorptiometry in 984 Hispanic children and adolescents

228 composition as measured by dual-energy X-ray absorptiometry in a large sample of twins from the Twins

229 BF% was measured by dual-energy x-ray absorptiometry in a population-based cross-sectional stu

230 and spine were detected by dual-energy x-ray absorptiometry in both groups.

231 and adiposity measured by dual-energy X-ray absorptiometry in US children.

232 tage body fat (measured by dual-energy X-ray absorptiometry) in adults in a large nationally represen

233 s and whole-body fat mass (dual-energy X-ray absorptiometry) increased over 12 weeks in Control by 1.

234 y weight was measured, and dual-energy X-ray absorptiometry, indirect calorimetry (men only), and gen

235 wer radiation emissions by dual-energy X-ray absorptiometry instruments now permit the safe measureme

236 essments of body composition (via dual X-ray absorptiometry), insulin sensitivity (via hyperinsulinem

237 Dual x-ray absorptiometry is currently the state-of-the-art techniq

238 ures, but correlation with dual-energy x-ray absorptiometry is low.

239 density (BMD) measured by dual-energy x-ray absorptiometry is used to assess bone health in kidney t

240 is of the relation between dual-energy x-ray absorptiometry-measured fat mass and BMI (in kg/m(2)) st

241 neonatal anthropometry and dual-energy X-ray absorptiometry measurements of neonatal lean mass in 102

242 f 8.2 years (766 follow-up dual energy X-ray absorptiometry measurements).

243 nsulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat dist

244 tin ratio (HMWr), 24-hr ABPM, and dual x-ray absorptiometry measures of fat mass were obtained.

245 implant sites were assessed with dual x-ray absorptiometry, microcomputed tomography, and histology.

246 of body fat (adiposity) by dual-energy x-ray absorptiometry, moderate-to-vigorous physical activity u

247 ined body composition with dual-energy X-ray absorptiometry, muscle strength with a handgrip dynamome

248 and body fat distribution (dual-energy x-ray absorptiometry) of rilpivirine (RPV) and EFV plus 2 nucl

249 n = 28,330) measured using dual energy X-ray absorptiometry or bioelectrical impedance analysis, adju

250 come was lean body mass by dual-energy x-ray absorptiometry over the 12 week treatment period in elig

251 position was measured annually by dual X-ray absorptiometry, physical activity by accelerometry, and

252 Dual-energy x-ray absorptiometry predicts fractures similarly for men and

253 asting blood samples and a dual-energy X-ray absorptiometry scan (subset of 650) from which metabolic

254 th the use of a total body dual-energy X-ray absorptiometry scan at 20 y of age.

255 a, referred for a baseline dual-energy x-ray absorptiometry scan from January 1, 1996, to March 28, 2

256 thropometric measurements, dual-energy X-ray absorptiometry scan, as well as dietary and activity ass

257 By dual-energy X-ray absorptiometry scan, body composition was unaltered at 3

258 ycemic clamp, VO2max test, dual-energy X-ray absorptiometry scan, underwater weighing, and muscle bio

259 Whole-body dual-energy X-ray absorptiometry scanning revealed that bone-mass accrual

260 Dual-energy X-ray absorptiometry scanning was done at baseline and week 48

261 mposition assessment using dual energy x-ray absorptiometry scanning with energy expenditure measured

262 try (hearing loss, 22.6%), dual-energy x-ray absorptiometry scans (low bone mineral density [BMD], 23

263 eatment with 2 consecutive dual-energy x-ray absorptiometry scans (mean interval, 4.5 years).

264 total and subregions) measured by dual x-ray absorptiometry scans and complete information on covaria

265 measures were derived from dual-energy X-ray absorptiometry scans at a mean age of 9.9 y.

266 d a subset with whole-body dual-energy X-ray absorptiometry scans at baseline and during follow-up.

267 tween the first and second dual-energy x-ray absorptiometry scans categorized as stable, detectable d

268 and 1998 who had received dual-energy x-ray absorptiometry scans for estimation of total body fat (T

269 y specific software on the dual-energy x-ray absorptiometry scans of lumbar spine in 39 KTR and 77 co

270 g of the trial, and serial dual-energy x-ray absorptiometry scans of the lumbar spine were performed.

271 bdominal CT scans and whole-body dual-energy absorptiometry scans over a 96-week period in human immu

272 in which serial whole-body dual-energy X-ray absorptiometry scans were performed.

273 al body fat, measured from dual energy x-ray absorptiometry scans, was the primary outcome.

274 %BF) was measured by using dual-energy X-ray absorptiometry; sleeping metabolic rate (SMR), respirato

275 Dual energy X-ray absorptiometry studies revealed increased central fat ma

276 ce imaging studies, dual-energy radiographic absorptiometry studies, and muscle biopsy.

277 percentage of fat by using dual-energy X-ray absorptiometry, symptoms of depression and anxiety, and

278 gility fractures at better dual-energy x-ray absorptiometry T-scores than those with postmenopausal o

279 There are limitations of dual-energy x-ray absorptiometry technology in this population, including

280 d the aBMD with the use of dual-energy X-ray absorptiometry, the distal radius and tibia bone microst

281 ' anthropometrics and used dual-energy X-ray absorptiometry to assess body composition at 1, 4, and 7

282 al muscle phenotypes using dual energy x-ray absorptiometry, ultrasound and isokinetic dynamometry.

283 estimated with the use of dual-energy X-ray absorptiometry, underwater weighing (UWW), and TBW.

284 lean body mass measured by dual-energy x-ray absorptiometry was analyzed as z scores.

285 Dual-energy X-ray absorptiometry was performed at baseline and 24-week int

286 ge in body fat measured by dual-energy X-ray absorptiometry was smaller (P = 0.001) in the CLA group

287 Dual-energy X-ray absorptiometry was used to assess body composition with

288 Dual-energy X-ray absorptiometry was used to assess body composition.

289 Dual-energy X-ray absorptiometry was used to calculate adiposity.

290 Dual-energy X-ray absorptiometry was used to measure total bone mineral co

291 BMD, measured using dual-energy x-ray absorptiometry, was assessed at the lumbar spine, femora

292 Using dual-energy X-ray absorptiometry, we compared lumbar spine, total hip, and

293 Cycle ergometry and dual-energy X-ray absorptiometry were obtained in 50 TX and 70 controls, a

294 Laboratory analysis and dual energy X-ray absorptiometry were performed at baseline and every 12 m

295 cords, accelerometers, and dual-energy X-ray absorptiometry were used to assess diet, activity, and b

296 etic resonance imaging and dual-energy x ray absorptiometry) were assessed using multivariable linear

297 mp), and body composition (dual-energy X-ray absorptiometry) were examined.

298 body-composition data (by dual-energy X-ray absorptiometry) were used.

299 fat-free mass, measured by dual-energy X-ray absorptiometry, were converted to calorie equivalents an

300 fat was measured by using dual-energy X-ray absorptiometry, whereas abdominal VAT and SAT cross-sect